Maybe Pfizer don’t want it Blue, however, someone else might looking at the last paragraph stating both products are subject to licensing discussions... 003 may still be worth a quid...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025